Arbutus Biopharma's total assets for Q1 2025 were $117.01M, a decrease of -11.16% from the previous quarter. ABUS total liabilities were $37.85M for the fiscal quarter, a 10.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.